Altshuler Shaham LTD Horizon Therapeutics Public LTD CO Transaction History

Altshuler Shaham LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$79.4 - $116.36 $25,328 - $37,118	319 New	319 $25,000
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $45,037 - $59,865	-627 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $31,222 - $39,325	-466 Reduced 42.63%	627 $46,000
Q3 2020 Nov 10, 2020	BUY	$55.23 - $79.93 $38,219 - $55,311	692 Added 172.57%	1,093 $85,000
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $453 - $854	15 Added 3.89%	401 $22,000
Q1 2020 May 12, 2020	BUY	$24.87 - $38.56 $9,599 - $14,884	386 New	386 $11,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.